Startup to grow its U.S. dealer client base from 1,500 to 20,000+ rooftops. Spyne will introduce a GenAI-powered unified automotive retail solution to revolutionize the complete retail journey for dealerships. NEW DELHI, Feb. 25, 2025 (GLOBE NEWSWIRE) — SpyneAI, a leading AI-powered visual merchandising platform for the automotive industry, has secured $16 million in Series […]
— New agreement spans packet core, signaling, charging & policy solutions India's Bharti Airtel and Ericsson (NASDAQ: ERIC) have strengthened their longstanding partnership through a new collaboration to deploy Ericsson's secure, high-performing 5G Core network offerings to the benefit of Airtel's millions of customers and enterprises across India. The collaboration will enable Airtel to seamlessly
HydrogenPro ASA (OSE: HYPRO): HydrogenPro has today reported its financial results for the fourth quarter 2024. Achievements and highlights: Q4 2024 revenues of NOK 70 million in Q4 2024, with 41% gross margin ANDRITZ and MHI invested NOK 70 million, plus NOK70 million by LONGi (pending ODI approval) with 22% premium New manufacturing line of
(Brussels:ONWD),(Euronext Amsterdam:ONWD), Study shows significant functional improvements after one year of ARC-EX Therapy Improvements were observed throughout one-year treatment period with no plateau Results demonstrate the importance of sustained access to ARC-EX Therapy EINDHOVEN, the Netherlands, Feb. 25, 2025 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord
HydrogenPro ASA (OSE: HYPRO): HydrogenPro has today reported its financial results for the fourth quarter 2024. Achievements and highlights: — Q4 2024 revenues of NOK 70 million in Q4 2024, with 41% gross margin — ANDRITZ and MHI invested NOK 70 million, plus NOK70 million by LONGi (pending ODI approval) with 22% premium — New
(Paris:SAN), Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Approval offers access to new treatment options for newly diagnosed MM patients Approval based on positive results from the IMROZ phase 3 study that demonstrated Sarclisa in combination with VRd significantly improved progression-free survival, compared to VRd alone in transplant-ineligible newly diagnosed multiple
(Brussels:ARGX),(NASDAQ:ARGX), February 25, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Tim Van Hauwermeiren, Chief Executive Officer, will present at the TD Cowen 45th Annual Healthcare Conference on Monday, March 3, 2025 at 11:50
51Talk, an online English language education platform, has announced plans to launch a comprehensive, AI-powered systems upgrade across its business operations within the coming months. Partnering with top tier global AI service providers, the company describes the new initiative as a mass integration of AI across every facet of its business, including teaching, customer acquisition,
Wilmington, Delaware, Feb. 25, 2025 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Otolaryngology Endoscopy Market by Type (Laryngoscopes, Nasopharyngoscopes, Rhinoscopes, Otoscope, and Others), Usability (Reusable and Disposable), and End User (Hospitals, Ambulatory Surgery Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2035″. According to the report, the “otolaryngology endoscopy market” was
— The Hong Kong Convention and Exhibition Centre reached maximum capacity, with nearly 10,000 in-person attendees from over 100 countries, solidifying the conference's position as a marquee event of the region. — The conference, and its 350+ side events held over the week, are estimated to have contributedHK$275m to the economy. — Sold-out event highlights